On the stock market since 2019, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 20% below its peak. The market has trimmed its expectations for the company.
Sales run at $34.5M a year. A small number, but proof the product has real buyers.
A loss of $43.9M against $34.5M in annual sales.
On our five-subject report card, GLEO sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: GLEO is a high-risk stock — not yet profitable, and its future rides on its product catching on.